ADMETatlas: an online database of peptide ADMET evidence toward peptide therapeutic development.

Peptide therapeutics are expanding rapidly, yet poor permeability and limited in vivo stability still decide whether a candidate reaches the clinic. Judging these properties is difficult, because one sequence can be studied as different molecular forms or products, and reported values carry different experimental contexts. Despite the continuous accumulation of measurements of peptide absorption, distribution, metabolism, excretion, and toxicity (ADMET), few open-access resources keep each value attached to the material tested and its assay context. Herein, we present ADMETatlas, a curated peptide ADMET, safety, and developability database. Currently, ADMETatlas contains 39 641 measurements at 17 measured end points across 37 467 canonical peptide identities, 110 drug products, and 10 computed descriptors. Each measurement retains its value, unit, formal end point, assay context, and primary reference. Peptide identities, molecular forms, and products are cross-linked at the resolution each source supports. In addition to browsing and retrieval, a developability module profiles single candidates and compares several side by side. Applications to GLP-1 receptor agonists and polymyxin B show how route and formulation change the reading of peptide pharmacokinetics. We hope that ADMETatlas will prove useful in evidence-based peptide optimization and condition-aware modeling. ADMETatlas is freely available, without registration, at https://admetatlas.scbdd.com/.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-11-13
DOI
https://doi.org/10.1093/nar/gkag1147
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

ADMETatlas: an online database of peptide ADMET evidence toward peptide therapeutic development.

Dongsheng Cao, Aiping Lyu, Jiacai Yi, Dejun Jiang et al.
2 links
PubMed
Computational Drug Discovery Methods
article

ADMETatlas: an online database of peptide ADMET evidence toward peptide therapeutic development.

Dongsheng Cao, Aiping Lyu, Jiacai Yi, Dejun Jiang, Xinyu Gu, Yao Tian, Xiangzheng Fu, Youchao Deng
article en

Abstract

Peptide therapeutics are expanding rapidly, yet poor permeability and limited in vivo stability still decide whether a candidate reaches the clinic. Judging these properties is difficult, because one sequence can be studied as different molecular forms or products, and reported values carry different experimental contexts. Despite the continuous accumulation of measurements of peptide absorption, distribution, metabolism, excretion, and toxicity (ADMET), few open-access resources keep each value attached to the material tested and its assay context. Herein, we present ADMETatlas, a curated peptide ADMET, safety, and developability database. Currently, ADMETatlas contains 39 641 measurements at 17 measured end points across 37 467 canonical peptide identities, 110 drug products, and 10 computed descriptors. Each measurement retains its value, unit, formal end point, assay context, and primary reference. Peptide identities, molecular forms, and products are cross-linked at the resolution each source supports. In addition to browsing and retrieval, a developability module profiles single candidates and compares several side by side. Applications to GLP-1 receptor agonists and polymyxin B show how route and formulation change the reading of peptide pharmacokinetics. We hope that ADMETatlas will prove useful in evidence-based peptide optimization and condition-aware modeling. ADMETatlas is freely available, without registration, at https://admetatlas.scbdd.com/.

PubMed
Central South University (CN), Hong Kong Baptist University (HK), Shenzhen University of Advanced Technology (CN)
Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon